# Dhruv S. Kazi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/dhruv-s-kazi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20,269 |
| Field | Health Systems, Economic Evaluations, Quality of Life |
| h-index | 50 |
| i10-index | 117 |
| Last Known Institution | Beth Israel Deaconess Medical Center |
| OpenAlex ID | https://openalex.org/A5016472411 |
| ORCID iD | https://orcid.org/0000-0002-9510-2979 |
| Works | 280 |

## Researcher papers

- [Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association](https://scholariq.org/papers/heart-disease-and-stroke-statistics-2023-update-a-report-from-the-american-heart/)
- [2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association](https://scholariq.org/papers/2024-heart-disease-and-stroke-statistics-a-report-of-us-and-global-data-from-the/)
- [2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines](https://scholariq.org/papers/2023-aha-acc-accp-aspc-nla-pcna-guideline-for-the-management-of-patients-with/)
- [2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease](https://scholariq.org/papers/2023-aha-acc-accp-aspc-nla-pcna-guideline-for-the-management-of-patients-with-2/)
- [Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease](https://scholariq.org/papers/cost-effectiveness-of-pcsk9-inhibitor-therapy-in-patients-with-heterozygous/)
- [Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050—Prevalence of Risk Factors and Disease: A Presidential Advisory From the American Heart Association](https://scholariq.org/papers/forecasting-the-burden-of-cardiovascular-disease-and-stroke-in-the-united-states/)
- [Forecasting the Economic Burden of Cardiovascular Disease and Stroke in the United States Through 2050: A Presidential Advisory From the American Heart Association](https://scholariq.org/papers/forecasting-the-economic-burden-of-cardiovascular-disease-and-stroke-in-the/)
- [Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy](https://scholariq.org/papers/cost-effectiveness-of-tafamidis-therapy-for-transthyretin-amyloid-cardiomyopathy/)
- [Cardiovascular Deaths During the COVID-19 Pandemic in the United States](https://scholariq.org/papers/cardiovascular-deaths-during-the-covid-19-pandemic-in-the-united-states/)
- [Rural-Urban Disparities in Outcomes of Myocardial Infarction, Heart Failure, and Stroke in the United States](https://scholariq.org/papers/rural-urban-disparities-in-outcomes-of-myocardial-infarction-heart-failure-and/)

## Researcher topics

- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Cardiovascular Health and Risk Factors](https://scholariq.org/topics/cardiovascular-health-and-risk-factors/)
- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)

## Researcher university

- [Beth Israel Deaconess Medical Center](https://scholariq.org/institutions/beth-israel-deaconess-medical-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.